Literature DB >> 10618526

Early immunisation with hepatitis B vaccine: a five-year study.

C Belloni1, A Pistorio, C Tinelli, J Komakec, G Chirico, D Rovelli, R Gulminetti, G Comolli, P Orsolini, G Rondini.   

Abstract

We evaluated the response to the recombinant Hepatitis B vaccine using an accelerated schedule versus the traditional schedule by studying the immunologic memory induced in 200 children with HBs-Ag negative mothers. At seroconversion, the traditional schedule presented a higher percentage of children with serum HBs-Ag concentrations over 100 mIU/ml than the accelerated schedule. After five years this difference was no longer statistically significant and children who presented anti-HBsAg concentrations below 10 mUI/ml received an additional booster dose which stimulated the antibody concentration to exceed 100 mIU/ml in all cases. Recombinant HBV vaccine induced better long term immunologic memory when it was administered earlier.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618526     DOI: 10.1016/s0264-410x(99)00414-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India.

Authors:  Zahid Hussain; Syed S Ali; Syed A Husain; Mohammad Raish; Deepika R Sharma; Premashis Kar
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults.

Authors:  Jing Li; Jun Yao; Huan Shan; Yongdi Chen; Zheng-gang Jiang; Jing-jing Ren; Kai-jin Xu; Bing Ruan; Shi-gui Yang; Bing Wang; Tian-sheng Xie; Qian Li
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia.

Authors:  Simone Santana Viana; Gustavo Santos Araujo; Gustavo Baptista de Almeida Faro; Lana Luíza da Cruz-Silva; Carlos André Araújo-Melo; Rosana Cipolotti
Journal:  Rev Bras Hematol Hemoter       Date:  2012

Review 4.  Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

Authors:  Gillian M Keating; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Persistence of HBV Vaccine's Protection and Response to Hepatitis B Booster Immunization in 5- to 7-Year-Old Children in the Kohgiloyeh and Boyerahmad Province, Iran.

Authors:  Behrouz Yazdanpanah; Mitra Safari; Shahrzad Yazdanpanah
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

6.  Two-year immune effect differences between the 0-1-2-month and 0-1-6-month HBV vaccination schedule in adults.

Authors:  Juan Wang; Chang-Hai Liu; Yuanji Ma; Xia Zhu; Liru Luo; Yulin Ji; Hong Tang
Journal:  BMC Infect Dis       Date:  2022-02-18       Impact factor: 3.090

7.  How does the immunogenicity of hepatitis B vaccine change over the years in childhood?

Authors:  Gulsum Iclal Bayhan; Sidika Elif Balli; Hatice Demir; Zekiye Baydar
Journal:  Hum Vaccin Immunother       Date:  2021-04-01       Impact factor: 3.452

8.  Rapid immunization scheme for spouses of individuals estabilished as hepatitis B carriers during premarital tests.

Authors:  Selma Tosun; Murat Yücetürk; Aydın Bilal Dönmez; Turan Gündüz
Journal:  Clin Dev Immunol       Date:  2012-12-13

9.  Comparison of the accelerated and classic vaccination schedules against Hepatitis B: three-week Hepatitis B vaccination schedule provides immediate and protective immunity.

Authors:  Nese Saltoğlu; A Seza Inal; Yesim Tasova; Ozlem Kandemir
Journal:  Ann Clin Microbiol Antimicrob       Date:  2003-11-17       Impact factor: 3.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.